Bioavailability Study of an Innovative Orobuccal Formulation of Glutathione

Author:

Buonocore Daniela1,Grosini Matteo1,Giardina Silvana2,Michelotti Angela2,Carrabetta Mariaelena1,Seneci Antonio1,Verri Manuela3ORCID,Dossena Maurizia3ORCID,Marzatico Fulvio1

Affiliation:

1. Laboratory of Pharmacobiochemistry, Nutrition and Nutraceuticals, Department of Biology and Biotechnology “L. Spallanzani”, University of Pavia, 27100 Pavia, Italy

2. Farcoderm Srl European Expertise Network for Wellness and Dermatology, San Martino Siccomario, 27028 Pavia, Italy

3. Laboratory of Pharmacology and Experimental Toxicology, Department of Biology and Biotechnology “L. Spallanzani”, University of Pavia, 27100 Pavia, Italy

Abstract

Alteration of the ubiquitous thiol tripeptide glutathione (GSH) is involved in oxidative stress, which plays a role in ageing; consequently, GSH is closely related to this process characterized by progressive decline in the efficiency of physiological function and increased susceptibility to disease. When circulating GSH decreases, oral administration might be considered a therapeutic benefit. Unfortunately, due to the hydrolysis of the tripeptide by intestinalγ-glutamyltransferase, dietary glutathione is not a major determinant for its increase. Aim of this work was to evaluate improvement of GSH systemic availability testing,in vitroandin vivo, an optimized orobuccal fast-slow release formulation tablet containing pure stabilized GSH.In vitroevaluation of the penetration capability of the innovative GSH-release formulation showed that GSH was well absorbed by the reconstructed oral epithelium and its absorption has features of time-dependence. In addition,in vivoresults, obtained from 15 healthy volunteers, were in favor of GSH level improvement in blood showing fast (after 30 and 60 minutes) absorption through oral mucosa. In conclusion, the intake of GSH formulated through optimized orobuccal fast-slow release tablets gave positive results in raising GSH blood concentration.

Funder

Progetto di Ricerca Finalizzata

Publisher

Hindawi Limited

Subject

Cell Biology,Ageing,General Medicine,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3